AIM ImmunoTech EPS Basic from Extraordinaries (Quarterly) Insights

AIM ImmunoTech, Inc. (AIM)

1.22 -0.07 (-5.43%) USD | NYAM | Jan 12, 12:00

View EPS Basic from Extraordinaries (Quarterly) for AIM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	--
Agenus, Inc.	--
Curis, Inc.	--
Protalix Biotherapeutics, Inc.	--
Armata Pharmaceuticals, Inc.	--